To date, telemedicine has been largely focused on "first contact visits." Psoriasis presents unique challenges, including the need for long-term management. Telemedicine offers opportunities to develop novel approaches such as exploring artificial intelligence (AI) solutions and the personal management of psoriasis care. IPC convened a working group to establish a road map for how IPC can aid the development and implementation of telemedicine focused on psoriasis diagnosis and management. The telemedicine working group, chaired by Alexander Navarrini and co-chaired by Joel Gelfand, is in the process of developing a consensus statement regarding telemedicine in psoriasis management.
Chair Alexander Navarini Switzerland
Co-chair Joel Gelfand USA
April Armstrong, USA Andrea Chiricozzi, Italy Vahid Diamei, Switzerland Mohamed El-Komy, Egypt Christophe Hsu, Switzerland Peter van de Kerkhof, Netherlands, IPC CMO Christy Langan, USA, IPC CEO Staff liaison: Tina Burke, USA
About IPC Our Strategic Plan IPC's plan for advancing knowledge and enhancing care for patients with psoriasis. READ MORE
IPC's plan for advancing knowledge and enhancing care for patients with psoriasis.
Latest news Latin American case seriesJanuary 19, 2022This case series looks at the characteristics of Latin American patients with psoriasis and confirmed or highly suspected COVID-19. New corporate memberJanuary 18, 2022IPC is pleased to welcome Arcutis Biotherapeutics, Inc. as a Bronze Level Corporate Member! Additional data added to the PsoProtect RegistryJanuary 17, 2022PsoProtect, a global registry for clinicians to report outcomes of COVID-19 in individuals with psoriasis, has updated their preliminary data and now includes 1,369 cases. New board membersJanuary 12, 2022Meet the three new key opinion leaders who have been elected to join our board. More News